New drug duo aims to reboot immune system against tough lung cancers
Disease control
Not yet recruiting
This study is testing whether a new drug, SX-682, combined with an existing immunotherapy drug (atezolizumab), can help control advanced non-small cell lung cancer that has worsened after standard chemotherapy and immunotherapy. It aims to see if this combination can help the pat…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 23, 2026 12:43 UTC